116
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens : A Systematic Review and Meta-analysis

      , , , , , ,
      JAMA Oncology
      American Medical Association (AMA)

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          If not promptly recognized, endocrine dysfunction can be life threatening. The incidence and risk of developing such adverse events (AEs) following the use of immune checkpoint inhibitor (ICI) regimens are unknown.

          Related collections

          Author and article information

          Journal
          JAMA Oncology
          JAMA Oncol
          American Medical Association (AMA)
          2374-2437
          February 01 2018
          February 01 2018
          : 4
          : 2
          : 173
          Article
          10.1001/jamaoncol.2017.3064
          5838579
          28973656
          b44201f0-46a1-415c-8ab3-de1cc9331f2e
          © 2018
          History

          Comments

          Comment on this article

          Related Documents Log